Tumor-combatting drugs could allow melanoma patients to live much longer. Immunotherapy could revolutionize cancer treatment. New drugs can work in different types of cancer and last years. The two-year survival rate for advanced melanoma has improved from 10 to 25% in the past few years. Some experimental drugs offer up to a 40% survival rate. Side effects include colitis, as well as liver, thyroid, and pituitary gland problems. Besides melanoma, these drugs also work on liver, kidney, and bladder cancer.
Pollack, Andrew. “New System for Treating Cancer Seen as Hopeful.” Health. The New York Times, 2 Jun 2014. Web. 29 Jul 2014.